why choose us

First received: January 25, 2023

Clinical Trial: CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: In-stent Restenosis

Study Type: Interventional


Official Title: Everolimus-Coated Percutaneous Transluminal Coronary Angioplasty Catheter First in Human Clinical Investigation: A Clinical Evaluation in the Treatment of Subjects With In-Stent Restenosis of Previous

Brief Summary: The goal of this first in human study is to assess the safety and inhibition of restenosis of the CVT Everolimus-coated PTCA Catheter in the treatment of subjects presenting in-stent restenotic lesions in native coronary arteries.

Read more